Document Detail


Vascular angiotensin pathways: a new therapeutic target.
MedLine Citation:
PMID:  2485070     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The renin-angiotensin system affects blood pressure and regional blood flow through endocrine, paracrine, and autocrine influences. The circulating endocrine renin-angiotensin system (RAS) is activated for acute cardiovascular homeostasis. The recent demonstration of a local renin-angiotensin system in the blood vessel wall has led us to speculate that the local production of angiotensin is involved with autocrine and paracrine control of vascular resistance. In addition to producing arteriolar constriction, arterial wall renin-angiotensin may influence the compliance of large conduit arteries. The production of angiotensin in the blood vessels may participate in hypertension and may influence blood pressure responses to the inhibitors of the RAS.
Authors:
V J Dzau
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review    
Journal Detail:
Title:  Journal of cardiovascular pharmacology     Volume:  10 Suppl 7     ISSN:  0160-2446     ISO Abbreviation:  J. Cardiovasc. Pharmacol.     Publication Date:  1987  
Date Detail:
Created Date:  1991-10-01     Completed Date:  1991-10-01     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  7902492     Medline TA:  J Cardiovasc Pharmacol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  S9-16     Citation Subset:  IM    
Affiliation:
Division of Vascular Medicine and Atherosclerosis, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Angiotensin II / biosynthesis,  metabolism,  physiology*
Arteries / metabolism
Blood Vessels / physiology*
Homeostasis / physiology
Humans
Renin-Angiotensin System / drug effects,  physiology*
Vascular Resistance
Grant Support
ID/Acronym/Agency:
HL 35610/HL/NHLBI NIH HHS; HL 35792/HL/NHLBI NIH HHS; HL35252/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
11128-99-7/Angiotensin II

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  In vitro inhibition of human renin by statine-containing tripeptide renin inhibitor (ES-1005).
Next Document:  Models for the three-dimensional structure of renin inhibitors bound in the active site of human ren...